Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An archaeomagnetic study of the Ishtar Gate, Babylon. | PLoS One | 2024 | 38232109 | PubTator, text mining | PubMed |
| Clinicopathological Significance and Expression Pattern of Bcl2 in Breast Cancer: A Comprehensive in silico and in vitro Study. | Saudi J Biol Sci | 2024 | 38223131 | PubTator, text mining | PubMed |
| High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation through downregulation of TIPE1. | Diabetol Metab Syndr | 2024 | 38216955 | PubTator, text mining | PubMed |
| The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. | BMC Cancer | 2024 | 38166752 | PubTator, text mining | PubMed |
| A CTL-Inspired Killing System Using Ultralow-Dose Chemical-Drugs to Induce a Pyroptosis-Mediated Antitumor Immune Function. | Adv Mater | 2024 | 38102944 | PubTator, text mining | PubMed |
| Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review). | Int J Oncol | 2024 | 38038050 | PubTator, text mining | PubMed |
| Construction of lncRNA/Pseudogene-miRNA Network Based on In Silico Approaches for Glycolysis Pathway to Identify Prostate Adenocarcinoma-Related Potential Biomarkers. | Appl Biochem Biotechnol | 2024 | 37542606 | PubTator, text mining | PubMed |
| Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax. | Haematologica | 2024 | 37534528 | PubTator, text mining | PubMed |
| Programmed cell death in tumor immunity: mechanistic insights and clinical implications. | Front Immunol | 2023 | 38283351 | PubTator, text mining | PubMed |
| A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects. | Pharmaceuticals (Basel) | 2023 | 38275993 | PubTator, text mining | PubMed |
| Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction. | Pharmaceutics | 2023 | 38258067 | PubTator, text mining | PubMed |
| Oxidative Stress Mediates Epigenetic Modifications and the Expression of miRNAs and Genes Related to Apoptosis in Diabetic Retinopathy Patients. | J Clin Med | 2023 | 38202081 | PubTator, text mining | PubMed |
| Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay. | Oncol Res | 2023 | 38186574 | PubTator, text mining | PubMed |
| Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers. | Front Immunol | 2023 | 38179042 | PubTator, text mining | PubMed |
| Deciphering the Hypoxia-immune interface in esophageal squamous carcinoma: a prognostic network model. | Front Oncol | 2023 | 38148838 | PubTator, text mining | PubMed |
| Oncoviruses: Induction of cancer development and metastasis by increasing anoikis resistance. | Heliyon | 2023 | 38144298 | PubTator, text mining | PubMed |
| Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines. | Viruses | 2023 | 38140619 | PubTator, text mining | PubMed |
| Glycyrol Prevents the Progression of Psoriasis-like Skin Inflammation via Immunosuppressive and Anti-Inflammatory Actions. | Int J Mol Sci | 2023 | 38139164 | PubTator, text mining | PubMed |
| Antitumor and Phytochemical Properties of Ferula assa-foetida L. Oleo-Gum-Resin against HT-29 Colorectal Cancer Cells In Vitro and in a Xenograft Mouse Model. | Molecules | 2023 | 38138502 | PubTator, text mining | PubMed |
| LLGL2 Inhibits Ovarian Cancer Metastasis by Regulating Cytoskeleton Remodeling via ACTN1. | Cancers (Basel) | 2023 | 38136424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=4